The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by King Thomas Braxton since 2007.
The trader's CIK number is 1279309.
At the time of the last reporting, King Thomas Braxton was the Pres & CEO of Alexza Pharmaceuticals Inc.. (stock ticker symbol ALXA).
Also see all insider trading activities at Alexza Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | ALXA | 40,000 | $179,349 | 0 | $0 | 0 | $0 |
| 2012 | ALXA | 0 | $0 | 75,516 | $63,504 | 0 | $0 |
| 2009 | ALXA | 64,655 | $149,999 | 44,994 | $100,273 | 0 | $0 |
| 2008 | ALXA | 0 | $0 | 37,500 | $230,449 | 0 | $0 |
| 2007 | ALXA | 0 | $0 | 25,000 | $204,525 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-24 | ALXA | Buy | 25,000 | 4.48 | 111,900 |
| 2013-07-25 | ALXA | Buy | 12,580 | 4.50 | 56,584 |
| 2013-07-26 | ALXA | Buy | 2,420 | 4.49 | 10,865 |
| 2012-08-27 | ALXA | Sale | 10,000 | 4.14 | 41,360 |
| 2012-06-06 | ALXA | Sale | 65,516 | .34 | 22,144 |
| 2009-12-16 | ALXA | Sale | 14,244 | 2.41 | 34,285 |
| 2009-12-17 | ALXA | Sale | 7,892 | 2.20 | 17,370 |
| 2009-12-18 | ALXA | Sale | 22,858 | 2.13 | 48,618 |
| 2009-10-05 | ALXA | Buy | 64,655 | 2.32 | 149,999 |
| 2008-08-11 | ALXA | Sale | 12,500 | 5.67 | 70,900 |
| 2008-05-12 | ALXA | Sale | 12,500 | 6.12 | 76,437 |
| 2008-02-11 | ALXA | Sale | 12,500 | 6.65 | 83,112 |
| 2007-11-09 | ALXA | Sale | 12,500 | 7.20 | 90,000 |
| 2007-08-08 | ALXA | Sale | 2,500 | 9.25 | 23,125 |
| 2007-08-09 | ALXA | Sale | 10,000 | 9.14 | 91,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by King Thomas Braxton (Pres & CEO of Alexza Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.